Prescription Weight Loss Pills Eligibility Private prescription: BMI 30+, or BMI 27+ with at least one weight-related comorbidity (PCOS, hypertension, dyslipidaemia, type 2 diabetes, sleep apnoea) NHS (Orlistat): BMI 30+, or BMI 28+ with additional risk factors NHS (GLP-1 injections via specialist services): BMI 35+ with at least one comorbidity Where injections win - Highest efficacy - Mounjaro and Wegovy 7.2mg injection currently outperform both oral options on average weight loss Already available in the UK Weekly dosing No fasting requirements When pills make more sense - Genuine needle phobia Frequent travel where cold storage is difficult Pills draw less attention than injectable pens You take levothyroxine and orforglipron suits your existing morning routine better than the Wegovy pill Well let you decide whats better
Offer terms are subject to change
Some individuals achieve 20%+ weight loss while others experience more modest results, partly reflecting these underlying genetic differences
Seed We previously reported that the gas chromatography/mass spectrophotometry of NSS revealed the presence of 27 bioactive phytochemical constituents
Common side effects include nausea, vomiting, and gastrointestinal disturbances
Freezing may compromise benzyl alcohol concentration and vial integrity